Audit Committee’s Review Affirms the Company Acted Properly with Regard to the Management-Led Buyout of FRG; B. Riley Financial and its Executives Had No Involvement with, or Knowledge of, Alleged Prophecy Misconduct LOS ANGELES, Feb. 22, 2024 /PRNewswire/ — The Board of Directors of B….
Month: February 2024
LOS ANGELES, Feb. 22, 2024 /PRNewswire/ — B. Riley Financial, Inc. (Nasdaq: RILY) will release results for the fourth quarter and full year ending December 31, 2023 after market close on Thursday February 29, 2024. Bryant Riley, Chairman and Co-CEO, Tom Kelleher, Co-CEO, and Phillip Ahn,…
MIAMI, Feb. 22, 2024 /PRNewswire/ — Matrix Renewables, the TPG Rise-backed global renewable energy platform, today announced that it has closed on the construction to term loan financing of $283 million and also executed a production tax credit (PTC) transfer agreement for its project…
LOS ANGELES, Feb. 22, 2024 /PRNewswire/ — PhorMed Inc. (PhorMed or Company) recently filed a Form C for the purpose of launching a Regulatory CF, equity crowdfunding campaign, on the platform WeFunder at https://wefunder.com/phormed. PhorMed is a clinical stage biopharmaceutical company…
Exceeded Fourth Quarter Guidance, Delivered 7% Year-Over-Year Revenue Growth Achieved 7% Year-Over-Year ARPD Growth coupled with Strong Fourth Quarter OEM Performance Generated $137MM of Annual Cash Flows From Operating Activities CHICAGO, Feb. 22, 2024 /PRNewswire/ — Cars.com Inc….
The ROSA® Shoulder System Becomes the First-to-Market Robotic Surgical Assistant for Shoulder Arthroplasty and the Fourth ROSA Robotics Application in Five Years WARSAW, Ind., Feb. 22, 2024 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology…
MACDILL AIR FORCE BASE, Fla., Feb. 22, 2024 /PRNewswire/ — Beacon AI, an artificial intelligence aviation technology company, was awarded a Phase 2 prototype Other Transaction Authority (OTA) agreement from U.S. Special Operations Command to enhance their AI copilot assistant to optimize…
— On track to provide update from ongoing Phase 1 clinical trial in mid-2024; additional data expected in 1H 2025 — BOSTON, Feb. 22, 2024 /PRNewswire/ — Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer…
New AUM Record: Valour reports a significant increase in assets under management (“AUM”), reaching C$590 million, up from C$497 million as of January 31, 2024. This 18.7% growth reflects strong market confidence and Valour’s expanding influence in the digital asset space. Launch of XRP…
NEW YORK and HÖSBACH, Germany, Feb. 22, 2024 /PRNewswire/ — LeapXpert, the responsible business communication pioneer, and ASC, a leading provider of recording and cloud solutions, today announced a partnership to deliver compliance recording for external Microsoft Teams voice and text…